Spinal cord brain-derived neurotrophic factor levels increase after dexamethasone treatment in male rats with chronic inflammation

NeuroImmunoModulation

Volumn 20, Issue 2, 2013, Pages 119-125

  Laste, Gabriela ^a,b   Ripoll Rozisky, Joanna ^a,b   De MacEdo, Isabel Cristina ^a,b   Souza Dos Santos, Vinicius ^a   Custódio De Souza, Izabel Cristina ^a   Caumo, Wolnei ^a   Torres, Iraci L S ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Antinociception; Brain derived neurotrophic factor; Dexamethasone; Spinal cord

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HOT PLATE TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC DISEASE; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREUND'S ADJUVANT; INFLAMMATION; MALE; PAIN; RATS; RATS, WISTAR; SPINAL CORD;

EID: 84872272274     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000345995     Document Type: Article

References (34)

1. Stahn C, Buttgereit F: Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008; 4: 525-533.
2. Zhang RX, Lao L, Qiao LT, Malsnee K, Ruda MA: Endogenous and exogenous glucocorticoid suppresses up-regulation of preprodynorphin mRNA and hyperalgesia in rats with peripheral inflammation. Neurosci Lett 2004; 359: 85-88.
3. Yoshida M, Koyanagi S, Matsuo A, Fujioka T, To H, Higuchi S, Ohdo: Glucocorticoid hormone regulates the circadian coordination of opioid receptor expression in mouse brainstem. J Pharmacol Exp Ther 2005; 315: 1119-1124.
4. Patte-Mensah C, Kibaly C, Boudard D, Schaeffer V, Begle A, Saredi S, Meyer L, Mensah-Nyagan AG: Neurogenic pain and steroid synthesis in the spinal cord. J Mol Neurosci 2006; 17: 28-32.
5. Gonzalez S, Moses DF, De Nicola AF: Glucocorticoid receptors and enzyme induction in the spinal cord of rats: effects of acute transection. J Neurochem 1990; 54: 834-840.
6. Marlier LN, Csikos T, Rebaudengo N, Borboni P, Patacchioli FR, Angelucci L, Privat A, Lauro R: Distribution of glucocorticoid receptor mRNA in the rat spinal cord. Neuroreport 1995; 6: 2245-2249.
7. Zhao J, Seereeram A, Nassar MA, Levato A, Pezet S, Hathaway G, Morenilla-Palao C, Stirling C, Fitzgerald M, McMahon SB, Rios M, Wood JN: Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Mol Cell Neurosci 2006; 31: 539-548.
8. Zhang HN, Ko MC: Seizure activity involved in the up-regulation of BDNF mRNA expression by activation of central mu opioid receptors. Neuroscience 2009; 161: 301-310.
9. Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C, Bardoni R: BDNF as a pain modulator. Prog Neurobiol 2008; 85: 297-317.
10. Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, Doperalski NJ, Johnson RA, Watters JJ, Mitchell GS: BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci 2004; 7: 48-55.
11. Schinder AF, Berninger B, Poo M: Postsynaptic target specificity of neurotrophin-induced presynaptic potentiation. Neuron 2000; 25: 151-163.
12. Turrigiano GG: The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 2008; 135: 422-435.
13. Swanwick CC, Murthy NR, Kapur J: Activity-dependent scaling of GABAergic synapse strength is regulated by brain-derived neurotrophic factor. Mol Cell Neurosci 2006; 31: 481-492.
14. Caparroz-Assef SM, Bersani-Amado CA, Kelmer-Bracht AM, Bracht A, Ishii-Iwamoto EL: The metabolic changes caused by dexamethasone in the adjuvant-induced arthritic rat. Mol Cell Biochem 2007; 302: 87-98.
15. Bernardi A, Zilberstein ACCV, Jäger E, Campos MM, Morrone FB, Calixto JB, Pohlmann AR, Guterres SS, Battastini AM: Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats. Br J Pharmacol 2009; 158: 1104-1111.
16. Rezazadeh SH, Zaringhalam J, Manakeji H, Kebryaeezadeh A: Anti-inflammatory and anti-hyperalgesic activities of Stachys athorecalyx extracts on CFA-induced inflammation. J Med Plant Res 2009; 5: 187-191.
17. Woolfe G, Macdonald AD: The evaluation of the analgesic action of pethidine hydrochloride. J Pharmacol Exp Ther 1944; 80: 300-307.
18. Yamamoto T, Nozaki-Taguchi N, Chiba T: Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot-plate test. Br J Pharmacol 2002; 137: 170-176.
19. Vivancos GG, Verri WA Jr, Cunha TM, Schivo IR, Parada CA, Cunha FQ, Ferreira SH: An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res 2004; 37: 391-399.
20. Kumamaru E, Numakawa T, Adachi N, Yagasaki Y, Izumi A, Niyaz M, Kudo M, Kunugi H: Glucocorticoid prevents brain-derived neurotrophic factormediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol Endocrinol 2008; 22: 546-558.
21. Bakowiec-Iskra E, Balkowiec A: Regulation of BDNF expression in trigeminal ganglion neurons by proinflammatory cytokines. Soc Neurosci Abstr 2009; 4: 7-10.
22. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y: BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005; 438: 1017-1021.
23. Lever IJ, Pezet S, McMahon SB, Malcangio M: The signaling components of sensory fiber transmission involved in the activation of ERK MAP kinase in the mouse dorsal horn. Mol Cell Neurosci 2003; 24: 259-270.
24. Malcangio M, Lessmann V: A common thread for pain and memory synapses? Brainderived neurotrophic factor and Trkb receptors. Trends Pharmacol Sci 2003; 24: 116-121.
25. Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q, Priestley JV: Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 1997; 17: 8476-8490.
26. Webster NJG, Pirrung MC: Small molecule activators of the Trk receptors for neuro protection. BMC Neurosci 2008, DOI:10.1186/1471-2202-9-S2-S1.
27. Fiumelli H, Kiraly M, Ambrus A, Magistretti PJ, Martin JL: Opposite regulation of calbindin and calretinin expression by brainderived neurotrophic factor in cortical neurons. J Neurochem 2000; 74: 1870-1877.
28. Zaringhalam J, Manaheji H, Mghsoodi N, Farokhi B, Mirzaiee V: Spinal mu-opioid receptor expression and hyperalgesia with dexamethasone in chronic adjuvant arthritis rats. Clin Exp Pharmacol Physiol 2008; 35: 1309-1315.
29. Millan MJ: The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 1-164.
30. Lam FF, Nq ES: Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats. Br J Pharmacol 2010; 159: 958-969.
31. Pinto-Ribeiro F, Moreira V, Pego JM, Leão P, Almeida A, Sousa N: Antinociception induced by chronic glucocorticoid treatment is correlated to local modulation of spinal neurotransmitter content. Molecular Pain 2009, DOI:10.1186/1744-8069-5-41.
32. da Silva JAP, Bijlsma JWJ: Optimizing glucocorticoid therapy of rheumatoid arthritis. Rheum Dis Clin North Am 2000; 26: 859-880.
33. Lavagno L, Gunella G, Bardelli C, Soina S, Fresu LG, Viano I, Brunelleschi S: Anti-inflammatory drugs and tumor necrosis factor-alpha production: role of transcription factor NF-kappa B and implications for rheumatoid arthritis therapy. Eur J Pharmacol 2004; 501: 199-208.
34. Oelzner P, Richter-Fleissner S, Bräuer R, Hein G, Wolf G, Neumann T: Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations is antigen-induced arthritis of the rat. Inflamm Res 2010; 59: 731-741.